STOCK TITAN

SNSE (NASDAQ: SNSE) insider schedules sale of 3,374 shares; prior sale 42,594

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SNSE submitted a Form 144 notice reporting a proposed Rule 144 sale of 3,374 common shares to be effected on 02/24/2026 pursuant to an option granted on 02/15/2023. The filing also discloses prior sales of 42,594 common shares on 02/19/2026 for $1,094,370.79.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 sale notice for insider shares; prior sales disclosed.

The filing lists a proposed sale of 3,374 common shares on 02/24/2026 tied to an option granted on 02/15/2023. It also reports prior sales of 42,594 shares on 02/19/2026 for $1,094,370.79.

This is a disclosure filing under Rule 144; timing and method are stated as cash. Any execution, settlement details, and whether volume limitations apply depend on market mechanics and are not detailed in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SNSE's Form 144 report about the proposed sale?

It reports a proposed sale of 3,374 common shares on 02/24/2026. The notice ties the sale to an option granted on 02/15/2023 and lists the sale method as cash.

How many shares did SNSE report were sold recently and for how much?

The filing shows 42,594 common shares sold on 02/19/2026 for $1,094,370.79. That entry is presented under "Securities Sold During The Past 3 Months" in the excerpt.

Who is identified as the selling/related party in the SNSE Form 144?

The excerpt lists John K. Celebi with an address in Rockville, MD. It also references Fidelity Brokerage Services LLC in the securities information section.

Is the Form 144 filing an instruction to sell or a notice of intent?

Form 144 is a notice of intent to sell under Rule 144. The excerpt shows the proposed sale date and past sales but does not itself execute a trade; actual transactions occur in the market.

Does the filing state how the shares will be sold?

The filing lists the method as "Cash." No further sale mechanics, broker instructions, or volume limits are provided in the excerpt.
Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

SNSE Rankings

SNSE Latest News

SNSE Latest SEC Filings

SNSE Stock Data

43.19M
856.66k
Biotechnology
Pharmaceutical Preparations
Link
United States
ROCKVILLE